Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views.

Gaetano AurilioMatteo SantoniFrancesco MassariAlessia CimadamoreAlessandro RizzoVeronica MollicaElena VerriNicola BattelliRodolfo Montironi

Published in: Cancers (2021)

In RCC patients, the PI3K/Akt signaling is still the most effective targetable pathway. Targeting other metabolic pathways such as c-Met, GSH, and HDAC appears to be a promising approach and deserve further insights.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
tyrosine kinase
drug delivery